nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—PAH—nervous system—Gilles de la Tourette syndrome	0.0153	0.0822	CbGeAlD
Epinephrine—PAH—central nervous system—Gilles de la Tourette syndrome	0.0147	0.0792	CbGeAlD
Epinephrine—PAH—brain—Gilles de la Tourette syndrome	0.0117	0.0629	CbGeAlD
Epinephrine—ADRBK1—nervous system—Gilles de la Tourette syndrome	0.0117	0.0628	CbGeAlD
Epinephrine—ADRBK1—central nervous system—Gilles de la Tourette syndrome	0.0113	0.0604	CbGeAlD
Epinephrine—ADRBK1—brain—Gilles de la Tourette syndrome	0.00893	0.048	CbGeAlD
Epinephrine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00688	0.037	CbGeAlD
Epinephrine—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.00673	0.0362	CbGeAlD
Epinephrine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00662	0.0356	CbGeAlD
Epinephrine—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.00648	0.0348	CbGeAlD
Epinephrine—L-DOPA—DRD4—Gilles de la Tourette syndrome	0.00647	0.164	CrCbGaD
Epinephrine—Dopamine—DRD4—Gilles de la Tourette syndrome	0.00601	0.153	CrCbGaD
Epinephrine—L-DOPA—DRD3—Gilles de la Tourette syndrome	0.00558	0.142	CrCbGaD
Epinephrine—ADRA1B—brain—Gilles de la Tourette syndrome	0.00526	0.0283	CbGeAlD
Epinephrine—Dopamine—DRD3—Gilles de la Tourette syndrome	0.00518	0.132	CrCbGaD
Epinephrine—ADRA1D—brain—Gilles de la Tourette syndrome	0.00514	0.0276	CbGeAlD
Epinephrine—SLC22A1—nervous system—Gilles de la Tourette syndrome	0.00508	0.0273	CbGeAlD
Epinephrine—ADRB1—nervous system—Gilles de la Tourette syndrome	0.00489	0.0263	CbGeAlD
Epinephrine—SLC22A1—central nervous system—Gilles de la Tourette syndrome	0.00489	0.0263	CbGeAlD
Epinephrine—Dopamine—SLC6A3—Gilles de la Tourette syndrome	0.00482	0.123	CrCbGaD
Epinephrine—ADRB1—central nervous system—Gilles de la Tourette syndrome	0.00471	0.0253	CbGeAlD
Epinephrine—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.00448	0.0241	CbGeAlD
Epinephrine—SLC22A5—midbrain—Gilles de la Tourette syndrome	0.00429	0.0231	CbGeAlD
Epinephrine—SLC22A1—brain—Gilles de la Tourette syndrome	0.00388	0.0209	CbGeAlD
Epinephrine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.00387	0.0208	CbGeAlD
Epinephrine—Norepinephrine—DRD2—Gilles de la Tourette syndrome	0.00386	0.098	CrCbGaD
Epinephrine—L-DOPA—DRD2—Gilles de la Tourette syndrome	0.00386	0.098	CrCbGaD
Epinephrine—ADRB1—brain—Gilles de la Tourette syndrome	0.00374	0.0201	CbGeAlD
Epinephrine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.00372	0.02	CbGeAlD
Epinephrine—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.00368	0.0198	CbGeAlD
Epinephrine—Dopamine—DRD2—Gilles de la Tourette syndrome	0.00359	0.0911	CrCbGaD
Epinephrine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.00358	0.0192	CbGeAlD
Epinephrine—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.00355	0.0191	CbGeAlD
Epinephrine—ADRA1A—brain—Gilles de la Tourette syndrome	0.00295	0.0159	CbGeAlD
Epinephrine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.00294	0.0158	CbGeAlD
Epinephrine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.00283	0.0152	CbGeAlD
Epinephrine—ADRA2C—brain—Gilles de la Tourette syndrome	0.00282	0.0151	CbGeAlD
Epinephrine—SLC22A5—brain—Gilles de la Tourette syndrome	0.0027	0.0145	CbGeAlD
Epinephrine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00231	0.0124	CbGeAlD
Epinephrine—ADRA2A—brain—Gilles de la Tourette syndrome	0.00225	0.0121	CbGeAlD
Epinephrine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00223	0.012	CbGeAlD
Epinephrine—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0012	0.00156	CbGpPWpGaD
Epinephrine—ADRB3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0012	0.00156	CbGpPWpGaD
Epinephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0012	0.00155	CbGpPWpGaD
Epinephrine—ADRA2B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00117	0.00151	CbGpPWpGaD
Epinephrine—SLC22A1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00113	0.00146	CbGpPWpGaD
Epinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00113	0.00146	CbGpPWpGaD
Epinephrine—ADRA2C—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00113	0.00145	CbGpPWpGaD
Epinephrine—ADRB3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00112	0.00145	CbGpPWpGaD
Epinephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00112	0.00145	CbGpPWpGaD
Epinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00112	0.00144	CbGpPWpGaD
Epinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0011	0.00143	CbGpPWpGaD
Epinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0011	0.00142	CbGpPWpGaD
Epinephrine—ADRA2C—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00109	0.00141	CbGpPWpGaD
Epinephrine—ADRA2B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00109	0.00141	CbGpPWpGaD
Epinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00109	0.0014	CbGpPWpGaD
Epinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00107	0.00138	CbGpPWpGaD
Epinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00106	0.00137	CbGpPWpGaD
Epinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00105	0.00135	CbGpPWpGaD
Epinephrine—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00103	0.00133	CbGpPWpGaD
Epinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00103	0.00133	CbGpPWpGaD
Epinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00103	0.00133	CbGpPWpGaD
Epinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00102	0.00132	CbGpPWpGaD
Epinephrine—ADRA2C—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00102	0.00131	CbGpPWpGaD
Epinephrine—ADRA1D—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00102	0.00131	CbGpPWpGaD
Epinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00101	0.00131	CbGpPWpGaD
Epinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00101	0.00131	CbGpPWpGaD
Epinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000999	0.00129	CbGpPWpGaD
Epinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000999	0.00129	CbGpPWpGaD
Epinephrine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000983	0.00127	CbGpPWpGaD
Epinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000967	0.00125	CbGpPWpGaD
Epinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00096	0.00124	CbGpPWpGaD
Epinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000959	0.00124	CbGpPWpGaD
Epinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000946	0.00122	CbGpPWpGaD
Epinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000945	0.00122	CbGpPWpGaD
Epinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000939	0.00121	CbGpPWpGaD
Epinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000931	0.0012	CbGpPWpGaD
Epinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00093	0.0012	CbGpPWpGaD
Epinephrine—SLC22A2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000929	0.0012	CbGpPWpGaD
Epinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000919	0.00119	CbGpPWpGaD
Epinephrine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000916	0.00118	CbGpPWpGaD
Epinephrine—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000915	0.00118	CbGpPWpGaD
Epinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000914	0.00118	CbGpPWpGaD
Epinephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000908	0.00117	CbGpPWpGaD
Epinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000895	0.00116	CbGpPWpGaD
Epinephrine—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000888	0.00115	CbGpPWpGaD
Epinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000887	0.00115	CbGpPWpGaD
Epinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000881	0.00114	CbGpPWpGaD
Epinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000875	0.00113	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000874	0.00113	CbGpPWpGaD
Epinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000869	0.00112	CbGpPWpGaD
Epinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000867	0.00112	CbGpPWpGaD
Epinephrine—SLC22A1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000866	0.00112	CbGpPWpGaD
Epinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000856	0.0011	CbGpPWpGaD
Epinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000855	0.0011	CbGpPWpGaD
Epinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000849	0.0011	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000848	0.0011	CbGpPWpGaD
Epinephrine—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000843	0.00109	CbGpPWpGaD
Epinephrine—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000827	0.00107	CbGpPWpGaD
Epinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000826	0.00107	CbGpPWpGaD
Epinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000824	0.00106	CbGpPWpGaD
Epinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00081	0.00105	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000809	0.00104	CbGpPWpGaD
Epinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000797	0.00103	CbGpPWpGaD
Epinephrine—SLC22A5—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000794	0.00102	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000793	0.00102	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00079	0.00102	CbGpPWpGaD
Epinephrine—ADRB3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000786	0.00102	CbGpPWpGaD
Epinephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000785	0.00101	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000785	0.00101	CbGpPWpGaD
Epinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000783	0.00101	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00077	0.000994	CbGpPWpGaD
Epinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000768	0.000991	CbGpPWpGaD
Epinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00076	0.000981	CbGpPWpGaD
Epinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000754	0.000973	CbGpPWpGaD
Epinephrine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000749	0.000967	CbGpPWpGaD
Epinephrine—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000737	0.000951	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000731	0.000944	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00073	0.000942	CbGpPWpGaD
Epinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000727	0.000939	CbGpPWpGaD
Epinephrine—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000721	0.00093	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000717	0.000926	CbGpPWpGaD
Epinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000715	0.000923	CbGpPWpGaD
Epinephrine—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000715	0.000923	CbGpPWpGaD
Epinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000709	0.000915	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000709	0.000915	CbGpPWpGaD
Epinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000708	0.000914	CbGpPWpGaD
Epinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000706	0.000912	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000701	0.000906	CbGpPWpGaD
Epinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0007	0.000903	CbGpPWpGaD
Epinephrine—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0007	0.000903	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000682	0.00088	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000681	0.000879	CbGpPWpGaD
Epinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000673	0.000868	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000672	0.000868	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000671	0.000866	CbGpPWpGaD
Epinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00067	0.000864	CbGpPWpGaD
Epinephrine—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000666	0.00086	CbGpPWpGaD
Epinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000662	0.000855	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000662	0.000855	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00066	0.000852	CbGpPWpGaD
Epinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000658	0.000849	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	0.000654	0.000844	CbGpPWpGaD
Epinephrine—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000652	0.000841	CbGpPWpGaD
Epinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000651	0.000841	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000651	0.000841	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000637	0.000822	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000634	0.000819	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000627	0.000809	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000618	0.000798	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000617	0.000796	CbGpPWpGaD
Epinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000613	0.000791	CbGpPWpGaD
Epinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000607	0.000784	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000607	0.000784	CbGpPWpGaD
Epinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000599	0.000774	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000596	0.00077	CbGpPWpGaD
Epinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000579	0.000747	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000579	0.000747	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000576	0.000744	CbGpPWpGaD
Epinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000567	0.000732	CbGpPWpGaD
Epinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000558	0.000721	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000554	0.000715	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000553	0.000714	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000539	0.000696	CbGpPWpGaD
Epinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000538	0.000694	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000538	0.000694	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.000531	0.000686	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000512	0.000661	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000503	0.000649	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000501	0.000647	CbGpPWpGaD
Epinephrine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000499	0.000645	CbGpPWpGaD
Epinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000496	0.00064	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000469	0.000605	CbGpPWpGaD
Epinephrine—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000467	0.000602	CbGpPWpGaD
Epinephrine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000465	0.000601	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000462	0.000597	CbGpPWpGaD
Epinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000461	0.000595	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000457	0.00059	CbGpPWpGaD
Epinephrine—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000456	0.000589	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000455	0.000587	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—MET—Gilles de la Tourette syndrome	0.00045	0.00058	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000444	0.000574	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000444	0.000573	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000432	0.000558	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000425	0.000549	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000424	0.000547	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000416	0.000538	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000415	0.000536	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000413	0.000534	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000413	0.000533	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000407	0.000526	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000404	0.000522	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000403	0.000521	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000403	0.00052	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.0004	0.000517	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000395	0.00051	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000385	0.000498	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000379	0.00049	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000378	0.000488	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000378	0.000487	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000376	0.000486	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000376	0.000486	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000375	0.000484	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000375	0.000484	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000374	0.000483	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000373	0.000482	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00037	0.000477	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000368	0.000476	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000368	0.000475	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000367	0.000474	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000365	0.000472	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000364	0.00047	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000359	0.000464	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000351	0.000453	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00035	0.000452	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000348	0.00045	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000344	0.000445	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	0.000343	0.000443	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000343	0.000443	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000342	0.000441	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00034	0.000439	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00034	0.000439	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000339	0.000437	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000337	0.000435	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000334	0.000432	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000334	0.000432	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000327	0.000422	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000316	0.000409	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000313	0.000404	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000311	0.000402	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000306	0.000395	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000305	0.000393	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000304	0.000392	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000297	0.000383	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000297	0.000383	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000293	0.000378	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000289	0.000374	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000284	0.000367	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000283	0.000365	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000277	0.000357	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000276	0.000356	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000264	0.00034	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000263	0.000339	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000261	0.000337	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000258	0.000333	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000257	0.000332	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000245	0.000316	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000244	0.000315	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00024	0.00031	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000239	0.000309	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000238	0.000308	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000238	0.000307	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000237	0.000306	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000234	0.000302	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000226	0.000292	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000223	0.000288	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000222	0.000286	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000222	0.000286	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000221	0.000286	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000218	0.000282	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000218	0.000282	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000217	0.00028	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000215	0.000277	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000213	0.000275	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000212	0.000274	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000207	0.000267	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000203	0.000263	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000202	0.000261	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000201	0.000259	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.0002	0.000258	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000198	0.000256	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000198	0.000255	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000197	0.000255	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000194	0.00025	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000187	0.000241	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000184	0.000238	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000181	0.000233	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00018	0.000232	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000175	0.000226	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000168	0.000217	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000163	0.000211	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000163	0.00021	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000155	0.0002	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000152	0.000196	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000141	0.000183	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00014	0.000181	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000138	0.000179	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000131	0.000169	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000129	0.000166	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000114	0.000148	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000106	0.000137	CbGpPWpGaD
